Company / PP&E per Share
AMICUS THERAPEUTICS, INC. PP&E per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest PP&E per Share
$0.09
FY2025
5-year range
$0.09 / $0.16
FY2021-FY2025
Trend
-9.4%
vs FY2024
Sector context
#105 of 191
Health Care
What the data says
At $0.09, AMICUS THERAPEUTICS, INC.'s pp&e per share ranks #105 of 191 in the Health Care sector. PP&E per Share has fluctuated over the past 10 years, ranging from $0.06 in FY2018 to $0.20 in FY2019.
Based on SEC 10-K filings.
0.09 in FY2025 with a 5-year CAGR of -11.8%.
Declined from $0.11 to $0.09 over the past 2 years.
Health Care sector context is included.
PP&E per Share over time
Growth rates
- 3-Year CAGR
- -6.3%
- 5-Year CAGR
- -11.8%
- 10-Year CAGR
- -
Sector benchmark
#105 of 191 in Health CareTop 55% of 191This company $0.09 Sector average $22.34
▼
-99.6% below sector average
Key checks
Key Insights
- In FY2025, pp&e per share decreased 9.4% year-over-year.
- Ranks #105 out of 191 companies in the Health Care sector.
- Peak pp&e per share was recorded in FY2019.
- Lowest pp&e per share in the period was in FY2018.
Company context
Key Data Points
- Altman Z-Score -1.19 (distress zone, below 1.8 threshold)
- Negative profit margin: -10.6%
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | PP&E per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $0.09 | -9.4% |
| FY2024 | $0.10 | -11.2% |
| FY2023 | $0.11 | +2.1% |
| FY2022 | $0.11 | -31.9% |
| FY2021 | $0.16 | -4.3% |
| FY2020 | $0.17 | -14.6% |
| FY2019 | $0.20 | +224.1% |
| FY2018 | $0.06 | -3.6% |
| FY2017 | $0.06 | -19.1% |
| FY2016 | $0.08 | +21.4% |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026